Drug intelligence / Profile preview

Shenhua Capsule

Development stage
Unknown
Lead developer
Air Force Military Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Shenhua Capsule (参华胶囊) is a Traditional Chinese Medicine (TCM) preparation developed by the Institute of Pharmacology at the Fourth Military Medical University of the People's Liberation Army of China. It is primarily indicated for the treatment of stable angina pectoris, coronary heart disease, and hypertension. The formulation is a combination of total saponins extracted from *Panax ginseng* (Ginseng) and extracts from *Salsola collina* (a plant known for its antihypertensive properties). Pharmacologically, Shenhua Capsule is designed to improve myocardial ischemia, reduce myocardial oxygen consumption, and inhibit platelet aggregation. It also exhibits vasodilatory effects that contribute to its antihypertensive and anti-anginal efficacy. Clinical studies in China have demonstrated its ability to alleviate symptoms such as chest pain and palpitations while improving electrocardiogram (ECG) markers in patients with ischemic heart disease.

Brand names
Shenhua Capsule参华胶囊
Other names
Shenhua Jiaonang
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)ATP1A1 (Sodium/potassium-transporting ATPase subunit alpha-1)

Beyond the preview

Go deeper on Shenhua Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenhua Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call